These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 9378241)

  • 21. Gastric mucosal apoptosis induced by ethanol: effect of antiulcer agents.
    Piotrowski J; Piotrowski E; Skrodzka D; Slomiany A; Slomiany BL
    Biochem Mol Biol Int; 1997 Jun; 42(2):247-54. PubMed ID: 9238522
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of ebrotidine on the synthesis and secretion of gastric sulfomucin.
    Slomiany BL; Lopez RA; Liau YH; Slomiany A
    Gen Pharmacol; 1993 May; 24(3):611-7. PubMed ID: 8365641
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nitric oxide in gastroprotective and ulcer healing effects of sucralfate.
    Konturek SJ; Brzozowski T; Pytko-Polonczyk J
    Scand J Gastroenterol Suppl; 1995; 210():22-7. PubMed ID: 8578200
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhancement in the protective qualities of gastric mucus with combination therapy of ebrotidine and amoxicillin for H. pylori eradication.
    Slomiany BL; Piotrowski J; Slomiany A; Konturek JW; Domschke WW
    Gen Pharmacol; 1998 Aug; 31(2):227-31. PubMed ID: 9688464
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cellular and molecular mechanisms of gastric ulcer healing. Is the quality of mucosal scar affected by treatment?
    Tarnawski A; Tanoue K; Santos AM; Sarfeh IJ
    Scand J Gastroenterol Suppl; 1995; 210():9-14. PubMed ID: 8578218
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and secretion of gastric sulfomucin in the presence of ebrotidine, a new antiulcer agent.
    Slomiany BL; Lopez RA; Slomiany A
    Biochem Int; 1992 Dec; 28(4):665-74. PubMed ID: 1482403
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of esomeprazole on healing of nonsteroidal anti-inflammatory drug (NSAID)-induced gastric ulcers in the presence of a continued NSAID treatment: Characterization of molecular mechanisms.
    Fornai M; Colucci R; Antonioli L; Awwad O; Ugolini C; Tuccori M; Fulceri F; Natale G; Basolo F; Blandizzi C
    Pharmacol Res; 2011 Jan; 63(1):59-67. PubMed ID: 20969958
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of sucralfate, lansoprazole, and cimetidine on the delayed healing by hydrocortisone sodium phosphate of chronic gastric ulcers in the rat.
    Kuwayama H; Matsuo Y; Eastwood GL
    Am J Med; 1991 Aug; 91(2A):15S-19S. PubMed ID: 1882902
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of basic fibroblast growth factor in the suppression of apoptotic caspase-3 during chronic gastric ulcer healing.
    Slomiany BL; Piotrowski J; Slomiany A
    J Physiol Pharmacol; 1998 Dec; 49(4):489-500. PubMed ID: 10069691
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Studies on the protective effect of ebrotidine on experimental ulcers induced by non-steroidal anti-inflammatory drugs in healthy volunteers.
    Puscas I; Puscas C; Coltau M; Torres J; Márquez M; Herrero E; Fillat O; Ortiz JA
    Arzneimittelforschung; 1997 Apr; 47(4A):565-8. PubMed ID: 9205766
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of sucralfate on gastric mucosal inflammatory responses induced by Helicobacter pylori lipopolysaccharide.
    Slomiany BL; Piotrowski J; Slomiany A
    Scand J Gastroenterol; 1998 Sep; 33(9):916-22. PubMed ID: 9759945
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gastric mucosal protection by sucralfate involves phosphoinositides participation.
    Slomiany A; Mizuta K; Piotrowski J; Nishikawa H; Slomiany BL
    Int J Biochem; 1990; 22(10):1179-83. PubMed ID: 1963155
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect and mechanism of sucralfate on healing of acetic acid-induced gastric ulcers in rats.
    Ogihara Y; Okabe S
    J Physiol Pharmacol; 1993 Jun; 44(2):109-18. PubMed ID: 8358048
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Helicobacter pylori aggregating activity of gastric mucin with ulcer healing by ebrotidine.
    Piotrowski J; Majka J; Piotrowski E; Murty VL; Gabryelewicz A; Slomiany A; Slomiany BL
    Biochem Mol Biol Int; 1994 Nov; 34(5):875-81. PubMed ID: 7535617
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ebrotidine.
    Patel SS; Wilde MI
    Drugs; 1996 Jun; 51(6):974-80; discussion 981. PubMed ID: 8736619
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of an antiulcer drug, sucralfate (a basic aluminum salt of sulfated disaccharide), on experimental gastric lesions and gastric secretion in rats.
    Okabe S; Takeuchi K; Kunimi H; Kanno M; Kawashima M
    Dig Dis Sci; 1983 Nov; 28(11):1034-42. PubMed ID: 6688779
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanism of ebrotidine protection against gastric mucosal injury induced by ethanol.
    Slomiany BL; Piotrowski J; Murty VL; Slomiany A
    Gen Pharmacol; 1992 Jul; 23(4):719-27. PubMed ID: 1356875
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of gastric mucosal calcium channel activity by an antiulcer agent, ebrotidine.
    Slomiany BL; Liu J; Piotrowski J; Czajkowski A; Yotsumoto F; Slomiany A
    J Physiol Pharmacol; 1994 Mar; 45(1):121-31. PubMed ID: 7519082
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fibroblast growth factor in gastroprotection and ulcer healing: interaction with sucralfate.
    Konturek SJ; Brzozowski T; Majka J; Szlachcic A; Bielanski W; Stachura J; Otto W
    Gut; 1993 Jul; 34(7):881-7. PubMed ID: 8344573
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quality of gastric ulcer healing. Is it influenced by antiulcer drugs?
    Tarnawski A; Santos AM; Hanke S; Stachura J; Douglass TG; Sarfeh IJ
    Scand J Gastroenterol Suppl; 1995; 208():9-13. PubMed ID: 7777811
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.